| RS2144814453 |
DSC2
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 11, Arrhythmogenic right ventricular dysplasia 11 |
| RS2144818920 |
DSC2
|
Health Risk |
Pathogenic |
— |
| RS2144822009 |
PRKCSH
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2144822115 |
HID1
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2144822186 |
PRKCSH
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2144823719 |
HERPUD1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2144826022 |
PRKCSH
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2144827923 |
STAT3
|
Health Risk |
Pathogenic/Likely pathogenic |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS2144828091 |
STAT3
|
Health Risk |
Pathogenic |
— |
| RS2144830115 |
SGSH
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS2144831005 |
FLCN
|
Health Risk |
Likely pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144832509 |
STAT3
|
Health Risk |
Likely pathogenic |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS2144832772 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2144833336 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 52 |
| RS2144833653 |
DSC2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 11, Arrhythmogenic right ventricular dysplasia 11 |
| RS2144837651 |
PRKCSH
|
Health Risk |
Likely pathogenic |
Polycystic liver disease 1, Polycystic liver disease 1 |
| RS2144839089 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144839173 |
DSC2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy |
| RS2144839279 |
FLCN
|
Health Risk |
Pathogenic |
— |
| RS2144839766 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2144840088 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2144840565 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS2144842978 |
DSC2
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 11, Arrhythmogenic right ventricular dysplasia 11 |
| RS2144843645 |
DSC2
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 11, Arrhythmogenic right ventricular dysplasia 11 |
| RS2144850365 |
DSC2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 11, Arrhythmogenic right ventricular dysplasia 11 |
| RS2144857383 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144858986 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome 1 |
| RS2144861585 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2144862529 |
LAMA3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2144869206 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2144869487 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144869904 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2144870247 |
FLCN
|
Health Risk |
Likely pathogenic |
— |
| RS2144870598 |
FLCN
|
Health Risk |
Pathogenic |
— |
| RS2144871276 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2144875247 |
ADAMTS18
|
Health Risk |
Likely pathogenic |
— |
| RS2144876596 |
ABCA7
|
Health Risk |
risk factor |
Alzheimer disease 9, Alzheimer disease 9 |
| RS2144880750 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2144883649 |
ABCA7
|
Health Risk |
Likely pathogenic |
— |
| RS2144887631 |
CACNA1A
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 6, Spinocerebellar ataxia type 6 |
| RS2144887794 |
BCAS3
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2144888569 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2144889289 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2144889523 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2144894376 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2144894415 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome 1, Birt-Hogg-Dube syndrome 1 |
| RS2144894596 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2144895051 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144896021 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2144896799 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2144897134 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2144897537 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144930944 |
FLCN
|
Health Risk |
Likely pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144931222 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144931929 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144932834 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144933364 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144935933 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2144936041 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2144936093 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 6, Spinocerebellar ataxia type 6 |
| RS2144936148 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2144947980 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144948439 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144950571 |
INSR
|
Health Risk |
Pathogenic |
— |
| RS2144952338 |
FLCN
|
Health Risk |
Pathogenic |
— |
| RS2144952476 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2144953455 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS2144954299 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2144954990 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS2144955129 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2144955398 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2144956340 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2144956632 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 6, Spinocerebellar ataxia type 6 |
| RS2144958410 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2144971536 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144972355 |
ABCA5
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2144972709 |
ZBTB7A
|
Health Risk |
Pathogenic |
Macrocephaly, neurodevelopmental delay |
| RS2144973210 |
ZBTB7A
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2144973693 |
ZBTB7A
|
Health Risk |
Pathogenic |
Macrocephaly, neurodevelopmental delay |
| RS2144974768 |
ZNF699
|
Health Risk |
Pathogenic |
DEGCAGS syndrome, DEGCAGS syndrome |
| RS2144976149 |
ZNF699
|
Health Risk |
Pathogenic |
DEGCAGS syndrome, DEGCAGS syndrome |
| RS2144979269 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 52 |
| RS2144979340 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144980363 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 52 |
| RS2144980726 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 52 |
| RS2144980732 |
ZNF699
|
Health Risk |
Pathogenic |
DEGCAGS syndrome, DEGCAGS syndrome |
| RS2144980758 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2144981510 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2144981630 |
FLCN
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS2144981673 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2144983515 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2144983543 |
FLCN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS2144989820 |
ZBTB7A
|
Health Risk |
Pathogenic |
Macrocephaly, neurodevelopmental delay |
| RS2144992092 |
ZBTB7A
|
Health Risk |
Pathogenic |
Macrocephaly, neurodevelopmental delay |
| RS2144994347 |
ZBTB7A
|
Health Risk |
Pathogenic |
Macrocephaly, neurodevelopmental delay |
| RS2144998926 |
BPTF
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies |
| RS2144999012 |
BPTF
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies |
| RS2145000036 |
BCAS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Global developmental delay, Hengel-Maroofian-Schols syndrome |
| RS2145002387 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |
| RS2145002415 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |